How GLP-1 Medications Affect Your Body GLP-1 receptor agonists mimic a natural hormone called glucagon-like peptide-1
The 5/5 vial gives equal parts of each, which is the ratio most closely matched by the published 1:1 blend protocols
Pedre B, Barayeu U, Ezeria D, Dick TP
Dosing Comparison# Retatrutide Dosing# Based on Phase 2 clinical trial protocols (investigational only): Starting dose : 0.5 mg weekly subcutaneous injection Escalation : Gradual increase over 12-24 weeks to target dose (up to 12 mg) Target doses tested : 1, 4, 8, and 12 mg weekly Escalation rationale : Extended 24-week escalation for higher doses reduces GI side effects compared to faster 12-week escalation No commercial formulation exists
doi: 10.1007/s10930-020-09935-8 267 TanB
Originally developed for type 2 diabetes, these therapies are now helping thousands achieve effective, doctor-supervised weight reduction